Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Impacts of Thyroid Eye Disease (TED), Beyond the Signs and Symptoms: Results from the ElevaTED Patient Survey.
Journal: Ophthalmology and therapy
Published: February 24, 2026
The Efficacy and Safety of Teprotumumab in Geriatrics Patients: A Multicenter Study.
Journal: Ophthalmic plastic and reconstructive surgery
Published: September 10, 2025
Correction: The role of IL-6 in thyroid eye disease: an update on emerging treatments.
Journal: Frontiers in ophthalmology
Published: June 04, 2025
Reply Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease".
Journal: Ophthalmic plastic and reconstructive surgery
Published: January 03, 2025
The role of IL-6 in thyroid eye disease: an update on emerging treatments.
Journal: Frontiers in ophthalmology
Published: December 12, 2024
Traumatic optic neuropathy management: a systematic review.
Journal: Eye (London, England)
Published: March 12, 2024
Teprotumumab for thyroid eye disease in patients with hypothyroid/euthyroid state: a multicenter case series.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: January 11, 2024
Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease.
Journal: Ophthalmic plastic and reconstructive surgery
Published: November 16, 2023
Bridging and Validation of the Specific Graves Ophthalmopathy Quality of Life Questionnaire With Health State Utility Values.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: November 15, 2023
Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter Study.
Journal: Ophthalmology
Published: July 13, 2023
Last Updated: 09/26/2026